IGFBP2 and central nervous system cancer: Exogenous IGFBP2 increases the proliferation and invasive capacity of the glioma cells, and induces chemoresistance, while knockdown of IGFBP2 resulted in both decreased invasiveness and tumorigenicity in nude mice [14,15].